Range Low Price High Price Comment
30 days $0.0560 $0.163 Wednesday, 27th Mar 2024 JAGX stock ended at $0.0729. This is 5.65% more than the trading day before Tuesday, 26th Mar 2024. During the day the stock fluctuated 7.41% from a day low at $0.0688 to a day high of $0.0739.
90 days $0.0519 $0.170
52 weeks $0.0519 $1.22

Historical Jaguar Health, Inc. prices

Date Open High Low Close Volume
2024-03-27 $0.0710 $0.0739 $0.0688 $0.0729 29 143 623
2024-03-26 $0.0728 $0.0730 $0.0653 $0.0690 41 435 870
2024-03-25 $0.0756 $0.0825 $0.0721 $0.0722 32 468 260
2024-03-22 $0.0800 $0.0802 $0.0700 $0.0719 50 821 768
2024-03-21 $0.0841 $0.0898 $0.0770 $0.0790 88 456 880
2024-03-20 $0.0990 $0.0999 $0.0731 $0.0799 189 266 361
2024-03-19 $0.0700 $0.0731 $0.0656 $0.0689 20 316 529
2024-03-18 $0.0732 $0.0735 $0.0662 $0.0694 19 960 978
2024-03-15 $0.0705 $0.0808 $0.0700 $0.0700 28 697 870
2024-03-14 $0.0760 $0.0783 $0.0710 $0.0751 27 557 320
2024-03-13 $0.0695 $0.0830 $0.0645 $0.0717 31 848 906
2024-03-12 $0.0720 $0.0750 $0.0660 $0.0683 20 170 099
2024-03-11 $0.0798 $0.0830 $0.0702 $0.0714 23 989 353
2024-03-08 $0.0830 $0.0880 $0.0812 $0.0815 19 516 871
2024-03-07 $0.0884 $0.0896 $0.0734 $0.0817 40 229 516
2024-03-06 $0.109 $0.110 $0.0850 $0.0896 54 589 675
2024-03-05 $0.126 $0.155 $0.115 $0.126 121 414 885
2024-03-04 $0.142 $0.163 $0.116 $0.143 342 272 970
2024-03-01 $0.0609 $0.108 $0.0600 $0.0885 282 986 148
2024-02-29 $0.0591 $0.0630 $0.0581 $0.0590 12 318 080
2024-02-28 $0.0600 $0.0609 $0.0561 $0.0577 19 748 774
2024-02-27 $0.0600 $0.0809 $0.0560 $0.0579 51 514 797
2024-02-26 $0.0614 $0.0660 $0.0591 $0.0600 19 656 918
2024-02-23 $0.0570 $0.0619 $0.0525 $0.0600 24 613 152
2024-02-22 $0.0696 $0.0696 $0.0519 $0.0570 25 164 520
Click to get the best stock tips daily for free!

About Jaguar Health, Inc.

Jaguar Health. Jaguar Health, Inc., a commercial stage pharmaceuticals company, focuses on developing prescription medicines for people and animals with gastrointestinal distress, specifically chronic, and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It markets Mytesi for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy. The company also develops Crofelemer fo... JAGX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT